Press release
Comprehensive Analysis of Pre-Eclampsia Pipeline Drugs (2023 Update): FDA Approvals, Clinical Trials, Therapeutic Approaches, Mechanisms of Action, and Route of Administration by DelveInsight
Pre-Eclampsia Pipeline
For Pre-Eclampsia emerging drugs, the Pre-Eclampsia pipeline analysis report provides a 360° view of the therapeutics landscape by development point, product type, route of administration, molecule type, and MOA. The pipeline research covers business opportunities, challenges, future partnerships, strong competitors, and growth strategies.
Request for sample page @ https://www.delveinsight.com/report-store/pre-eclampsia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the Pre-Eclampsia Pipeline Report
• Different Pre-Eclampsia pipeline therapies are in various stages of development, and their anticipated acceptance in the Pre-Eclampsia market would significantly increase market revenue.
• Leading Pre-Eclampsia companies developing novel drug candidates to improve the Pre-Eclampsia treatment landscape include Kyowa Kirin Co., Ltd, Pharming Group, Amag Pharmaceuticals, MirZyme, Evergreen Therapeutics, Dilafor, and others.
• Promising Pre-Eclampsia pipeline therapies in various stages of development include KW3357, rhC1INH protein replacement therapy, siRNA therapy, C103, GMA312, Tafoxiparin, EG-101, and others.
• In Aug 2023, Comanche Biopharma Receives US FDA Fast Track Designation for CBP-4888 for the Treatment of sFlt-1 mediated pre-term preeclampsia
Request a sample and discover the recent breakthroughs happening Pre-Eclampsia pipeline landscape in @ https://www.delveinsight.com/sample-request/pre-eclampsia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Pre-Eclampsia Overview
Pre-Eclampsia is a pregnancy complication marked by high blood pressure and signs of organ damage, most commonly the liver and kidneys. Pre-Eclampsia is a pregnancy condition characterized by hypertension (high blood pressure) and proteinuria (the presence of protein in your urine). It usually appears during the third trimester. The condition affects between 5% and 8% of pregnancies and has serious health consequences for mothers and babies. There is no single cause, but genetic factors and blood vessel problems are two possibilities. Pre-Eclampsia, if left untreated, can cause serious - even fatal - complications for both mother and baby.
Pre-Eclampsia Pipeline Analysis: Drug Profile
• Tafoxiparin: Dilafor
Tafoxiparin, a proprietary heparan sulfate mimetic, has been shown in preclinical and clinical data to supplement and fulfill the role of heparan sulfate, which is required for optimal oxytocin effectiveness. Tafoxiparin's mechanism of action has been supported by preclinical experiments and clinical studies when used in conjunction with oxytocin in current clinical practice. Tafoxiparin can improve uterine contractions and may promote cervical softening, potentially lowering the incidence of protracted labor and its associated complications. The drug is currently in Phase III development for the treatment of preeclampsia.
• KW3357: Kyowa Kirin Co., Ltd.
KW-3357 is an antithrombin (AT) drug developed using recombinant DNA and sugar-chain control technology. It is a recombinant AT preparation with the same amino acid sequence and sugar chain structure as human natural AT. AT inhibits blood coagulation by forming a complex with the proteolytic enzyme's coagulation factor. Since July 2015, KW-3357 has been approved in Japan for treating thrombophilia due to congenital AT deficiency (CAD) and disseminated intravascular coagulation (DIC) and is marketed under the brand name ACOALAN. Kyowan Kirin Co., Ltd is currently developing KW3357 in collaboration with Japan Blood Products Organization for Preeclampsia.
Pre-Eclampsia Pipeline Therapies and Key Companies
• KW3357: Kyowa Kirin Co., Ltd.
• rhC1INH protein replacement therapy: Pharming Group
• Tafoxiparin: Dilafor
• EG-101: Evergreen Therapeutics
• Preeclampsia Research Project: MirZyme
• siRNA therapy: Comanche Biopharma
• C 103: Vicore Pharma
• GMA 312: Gmax Biopharm
Learn more about the Pre-Eclampsia emerging pipeline therapies @ https://www.delveinsight.com/sample-request/pre-eclampsia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Pre-Eclampsia Pipeline Therapeutics Assessment
By Product Type
• Monotherapy
• Combination Therapy
By Stage
• Discovery
• Pre-Clinical
• Phase I
• Phase II
• Phase III
• Pre-registration
By Route of Administration
• Subcutaneous
• Intravenous
• Oral
By Molecule Type
• Replacement Therapy
• Physiological Saline
• Antihypertensive
Scope of the Pre-Eclampsia Pipeline Report
• Coverage: Global
• Key Pre-Eclampsia Companies: Kyowa Kirin Co., Ltd, Pharming Group (AMS: PHARM), Amag Pharmaceuticals, MirZyme, Evergreen Therapeutics, Dilafor, and others.
• Key Pre-Eclampsia Pipeline Therapies: KW3357, rhC1INH protein replacement therapy, siRNA therapy, C103, GMA312, Tafoxiparin, EG-101, and others.
Dive deep into rich insights for Pre-Eclampsia emerging therapies and assessment; visit @ @ https://www.delveinsight.com/sample-request/pre-eclampsia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1.Introduction
2.Pre-Eclampsia Executive Summary
3.Pre-Eclampsia Overview
4.Pre-Eclampsia Pipeline Therapeutics
5.Pre-Eclampsia Pipeline: Late Stage Products (Phase III)
6.Pre-Eclampsia Pipeline: Mid Stage Products (Phase II)
7.Pre-Eclampsia Pipeline: Early Stage Products (Phase I/II)
8.Pre-Eclampsia Pipeline: Preclinical Stage Products
9.Pre-Eclampsia Pipeline: Discovery Stage Products
10.Pre-Eclampsia Pipeline Therapeutic Assessment
11.Pre-Eclampsia Pipeline: Inactive Products
12.Collaborations Assessment- Licensing / Partnering / Funding
13.Unmet Needs
14.Market Drivers and Barriers
15.Appendix
16.About DelveInsight
For further information on the Pre-Eclampsia current pipeline therapeutics, reach out @ https://www.delveinsight.com/sample-request/pre-eclampsia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Chronic Pruritus Market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/orthotic-devices-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Adult Growth Hormone Deficiency Market: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Global Electrophysiology Devices Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Chronic Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
Contact Us:
Ankit Nigam
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Analysis of Pre-Eclampsia Pipeline Drugs (2023 Update): FDA Approvals, Clinical Trials, Therapeutic Approaches, Mechanisms of Action, and Route of Administration by DelveInsight here
News-ID: 3326997 • Views: …
More Releases from DelveInsight Business Research
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR…
Global Spinal Implants Market to reach USD 21,899.24 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing prevalence of spinal disorders, especially among the aging population, has substantially driven the demand for corrective surgical procedures. At the same time, the rise in sports-related and trauma-induced spinal injuries is boosting the need for advanced implantable solutions. Additionally, there is a growing preference for non-fusion and motion-preserving devices that maintain spinal mobility and improve patient outcomes, particularly among younger and more active individuals.…
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing global incidence of cancer is boosting the demand for effective treatment options such as tumor ablation. Minimally invasive procedures are becoming more popular due to their shorter recovery periods, reduced risks, and cost-effectiveness compared to conventional surgery. At the same time, technological advancements in tumor ablation devices-such as improvements in radiofrequency, microwave, and cryoablation technologies-have enhanced precision, safety, and effectiveness, making these procedures increasingly…
Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The increasing prevalence of cardiovascular disorders, along with risk factors like hypertension, diabetes, and obesity, is fueling the demand for surgical interventions, thereby supporting the growth of the vascular graft market. Moreover, greater awareness and the expansion of cardiovascular screening programs are enabling earlier diagnosis and timely treatment, further driving the need for vascular grafts.
DelveInsight's "Vascular Grafts Market Insights, Competitive Landscape and Market Forecast-2032" report provides…
More Releases for Pipeline
Refined Petroleum Products Pipeline Transportation Market: Insights, Trends and …
Refined Petroleum Products Pipeline Transportation Market Overview:
Refined petroleum products pipeline transportation industry comprises establishments primarily engaged in the pipeline transportation of refined petroleum products.. The global Refined Petroleum Products Pipeline Transportation Report contents include Size in value for the Refined Petroleum Products Pipeline Transportation market, drivers, trends and challenges, by end user, and growth rate during the forecast period, 2023-2030. Historical figures are also provided.
Get Sample Report @ https://reportsinsights.com/sample/671217
Key Competitors…
Presbyopia Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companie …
DelveInsight's, "Presbyopia Pipeline Insight, 2022," report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Presbyopia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key takeaways from the Presbyopia Pipeline Insight Report
• Presbyopia Pipeline report offers a comprehensive…
Scleroderma Pipeline | 20+ Key Players & 22+ Pipeline Drugs | DelveInsight
DelveInsight's, "Scleroderma Pipeline Insight, 2022," report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Scleroderma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key takeaways from the Scleroderma Pipeline Insight Report
• DelveInsight's analysis depicts a robust…
Malaria Pipeline Landscape Analysis: 15+ Key Players & 20+ Pipeline Drugs
DelveInsight's, "Malaria Pipeline Insight, 2022," report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Malaria pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
In the Malaria Pipeline report, detailed description of the drug is given which…
Refined Petroleum Products Pipeline Transportation Market is Booming with Strong …
Refined Petroleum Products Pipeline Transportation Market Report research report is a wide-ranging analysis and Impact of COVID19 in the global market and the in-detail information with segmentation has been added in this intelligence report. In this report a comprehensive analysis of current global Global Refined Petroleum Products Pipeline Transportation Market market in terms of demand and supply environment is provided, as well as price trend currently and in the next…
Refined Petroleum Products Pipeline Transportation Global Market 2018: Key Playe …
Refined petroleum products pipeline transportation industry comprises establishments primarily engaged in the pipeline transportation of refined petroleum products.
Introduction of new and advanced technologies in the industry is highly increasing the demand of refined petroleum products pipeline transportation market. Several countries has begun with the usage of drones and advanced surveillance systems for pipeline monitoringand also to protect oil pipelines from any disrupt acts. With these new robotics and IoT solutions…
